Whilst efforts to further improve the levels of CFTR correction will undoubtedly continue, the targeting of alternative ion channels to improve airway hydration and mucociliary clearance represents a promising complementary strategy that would have the added benefit of working in a mutation-agnostic fashion, which could have broad benefit across the CF population as a whole. This evidence concerns the gene CFTR and cystic fibrosis.